Tower Research Capital LLC (Trc) Pulmonx Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Pulmonx Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,323 shares of LUNG stock, worth $22,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,323
Previous 6,269
144.42%
Holding current value
$22,831
Previous $16,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding LUNG
# of Institutions
114Shares Held
31.3MCall Options Held
20.7KPut Options Held
0-
Primecap Management CO Pasadena, CA4.96MShares$7.39 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.62MShares$5.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$3.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.24MShares$3.34 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.26MShares$1.88 Million0.01% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $55.5M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...